Cargando…
Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics
The increase in pandemics caused by RNA viruses of zoonotic origin highlights the urgent need for broad-spectrum antivirals against novel and re-emerging RNA viruses. Broad-spectrum antivirals could be deployed as first-line interventions during an outbreak while virus-specific drugs and vaccines ar...
Autores principales: | Taroncher-Oldenburg, Gaspar, Müller, Christin, Obermann, Wiebke, Ziebuhr, John, Hartmann, Roland K., Grünweller, Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001013/ https://www.ncbi.nlm.nih.gov/pubmed/33807988 http://dx.doi.org/10.3390/microorganisms9030540 |
Ejemplares similares
-
Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates
por: Obermann, Wiebke, et al.
Publicado: (2023) -
The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo
por: Müller, Christin, et al.
Publicado: (2021) -
Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol
por: Müller, Christin, et al.
Publicado: (2020) -
Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity
por: Obermann, Wiebke, et al.
Publicado: (2022) -
Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
por: Müller, Christin, et al.
Publicado: (2018)